CGD's Javier Guzman speaks with the Indian National Health Authority's Shankar Prinja about the structure and benefits of the PMJAY insurance scheme, the challenges of large-scale programs, and the need for researchers and policymakers to work together to produce and make use of evidence on what wor...

We worked with the Joint Learning Network (JLN) Efficiency Collaborative to gain insights from Collaborative members who represent technical staff and decision-makers working at the heart of health benefit packages development and revisions in eleven low-and middle-income countries in Africa and Asi...

As the COVID-19 pandemic continues to rage and public funding is increasingly scarce, the need for high-quality, timely evidence on the effectiveness of public programs has never been clearer. In this blog, we share a top-line summary of the methodological and data advances alongside recommenda...

Today, we are excited to launch a background paper by our colleague Abeba Taddese that explores how these partnerships work, barriers that hinder progress, and ideas for what funders can do to help advance partnership models (alongside a complementary piece focused on rapid rigorous evaluations). Th...

An estimated $15.9 trillion has been mobilised to respond to the health and economic impact of the COVID-19 pandemic. Some of this has gone to multilateral and bilateral funders to support low- and middle-income countries’ (LMIC) governments. But how is this money being spent, and how is it impactin...

With the 2019 Nobel prize for economics going to Western economists combating poverty in LMICs through RCT-generated evidence, the time is ripe for the global community and national leaders to invest in a similar and yet different type of capacity: local pragmatic research infrastructure for learnin...

As countries strive to achieve the Sustainable Development Goals, including attaining and sustaining universal health coverage, decision-makers are increasingly using economic evaluation to drive macro policy choices and more granular technology-focused decisions. In a recent study, we discuss ...

On World AIDS Day, December 1, we honor the advocates that transformed HIV/AIDS from a death sentence to a chronic disease. These activists bequeathed a golden age of global health—a boom in money and programs that is sustained today, evidenced by the recent reauthorization of PEPFAR. But...